icobrain-ctp

by Icometrix NV  · Based in Belgium → — The global standard in AI-powered neuroimaging.
Neurology Neurosurgery Radiology

Not publicly disclosed.
Regulatory Status Disclosed

Overview

icobrain-ctp, developed by Icometrix NV, is an AI-powered image processing software package designed for trained professionals, including physicians and medical technicians. It is used for the analysis and communication of computed tomography (CT) perfusion scans of the brain. The software runs on a standard ‘off-the-shelf’ computer or a virtual platform like VMware.

It provides capabilities for dynamic imaging datasets acquired with CT Perfusion imaging protocols, including the calculation of parameters related to tissue flow (perfusion) and tissue blood volume. Specific computed parameter maps include Cerebral Blood Flow (CBF), Cerebral Blood Volume (CBV), Mean Transit Time (MTT), and Tissue residue function time to peak (TMax). Data and images are acquired through DICOM-compliant imaging devices, and results, including CT perfusion parameter maps, are exported in standard DICOM format for viewing on existing radiological imaging viewers.

icobrain-ctp is part of the broader icobrain platform, which offers AI solutions for various neurological disorders by extracting clinically meaningful data from both MRI and CT scans. The platform aims to assist radiologists and neurologists in diagnosing neurological conditions, monitoring progression, and improving outcomes efficiently and objectively.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Image processing, analysis, and communication of CT perfusion scans
  • Calculation of Cerebral Blood Flow (CBF), Cerebral Blood Volume (CBV), Mean Transit Time (MTT), and Tissue residue function time to peak (TMax)
  • DICOM-compliant data acquisition and export
  • Runs on standard off-the-shelf computers or virtual platforms (e.g., VMware)
  • Automated quantitative reports
  • Color-coded segmentations for highlighting key findings
  • Pre-populated radiological reporting templates
  • Seamless integration with PACS and EMR systems (via icobridge)
  • AI-powered analysis for neurological disorders
  • Longitudinal monitoring of brain changes

Use Cases

  • Diagnosis and monitoring of stroke through CT perfusion analysis
  • Assessment of acute impacts of brain trauma, including midline shift and hyperdensity volumes
  • Supporting differential diagnosis and monitoring of atrophy in dementia and Alzheimer's disease
  • Accurate visualization of lesion and brain volume changes over time in multiple sclerosis
  • Detecting, measuring, and grading Amyloid-Related Imaging Abnormalities (ARIA)
  • Supporting differential diagnosis of epilepsy through abnormality patterns

What Physicians Need to Know

Stroke Detection Speed
Provides fast, fully automated insights for acute ischemic stroke treatment decisions. Processing time for analysis is typically within 1 to 10 minutes.
Brain MRI/CT Analysis
Specializes in image processing and analysis of Computed Tomography Perfusion (CTP) scans of the brain. It calculates key perfusion parameters including Cerebral Blood Flow (CBF), Cerebral Blood Volume (CBV), Mean Transit Time (MTT), and Tissue residue function time to peak (TMax). The tool quantifies core and perfusion lesion volumes, Tmax and CBF abnormalities, and mismatch ratios, utilizing patented deep learning technology for robust assessment of infarcted areas.
Large Vessel Occlusion Detection
While not explicitly stated as a direct 'detection' feature for LVO on CTA, the tool's comprehensive CT perfusion analysis (quantifying core and penumbra) is critical for guiding treatment decisions in acute ischemic stroke, which frequently involves large vessel occlusions.
Triage Prioritization Speed
Offers fast, fully automated insights to support acute stroke treatment decisions, enhancing efficiency in acute clinical settings by providing rapid assessment of tissue parameters. This can streamline 'code stroke' workflows.
Mobile Notification System
As a cloud-based solution, it returns reports and perfusion maps directly into PACS and e-mail inboxes, enabling access and notification on mobile devices.
Physician Tip

Leverage icobrain-ctp for rapid, objective, and quantitative assessment of CT perfusion parameters in acute ischemic stroke cases. The automated analysis of core and penumbra volumes, along with CBF, CBV, MTT, and TMax maps, provides crucial data to support timely treatment decisions, especially within expanded thrombectomy windows. Integrate these insights with non-contrast CT and CT angiography findings for a comprehensive stroke evaluation. The standardized reports can enhance consistency and reduce inter-reader variability.

icobrain-ctp is designed for seamless integration into existing clinical workflows. It acquires data from DICOM-compliant imaging devices and exports processed results, including perfusion parameter maps, in standard DICOM format for viewing on existing radiological imaging viewers. The cloud-based solution delivers reports and perfusion maps directly to Picture Archiving and Communication Systems (PACS) and e-mail inboxes. Icometrix also utilizes 'icobridge' to connect MRI scanners, PACS, and Electronic Medical Record (EMR) systems, facilitating secure data transfer and automated report generation.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Not publicly disclosed. — Not publicly disclosed.
DeploymentSoftware-as-a-service (SaaS) deployed on standard computers or virtual platforms (e.g., VMware), integrating with hospital PACS and EMR systems.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

icobrain-ctp received FDA 510(k) clearance on February 28, 2020, under K192962. It is classified as a Class II medical device (21 CFR 892.2050 - Picture archiving and communications system) and is intended for image processing, analysis, and communication of computed tomography (CT) perfusion scans of the brain.

Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

What the Web Says

Icobrain-ctp is an AI-powered software designed to analyze CT perfusion scans of the brain, providing quantitative data for various neurological conditions. It aims to automate and standardize the interpretation of brain imaging, assisting physicians in diagnosing, monitoring disease progression, and assessing treatment response for conditions like stroke, traumatic brain injury, multiple sclerosis, and dementia. The software has received FDA clearance and CE marking, and new CPT-III codes for icobrain's quantitative brain MRI analysis became active in January 2024, facilitating reimbursement from over 30 insurers in the U.S.

Overall: Positive

Strengths

  • Automates and standardizes brain image analysis, reducing subjective interpretation and inter-center variation.
  • Provides objective quantitative data on brain volumes, lesions, and perfusion, aiding in earlier and more accurate diagnosis and monitoring of neurological conditions.
  • Enhances collaboration between radiologists and neurologists by providing comprehensive and standardized reports.
  • Can help predict disease progression and optimize treatment strategies, particularly in conditions like multiple sclerosis.
  • FDA-cleared and CE-marked, with established CPT-III codes for reimbursement, indicating regulatory approval and increasing accessibility.
  • Demonstrated to improve sensitivity and detection for Amyloid-Related Imaging Abnormalities (ARIA) in Alzheimer's treatments, enhancing patient safety.

Limitations

  • Real-time collection and analysis of evidence for broad clinical adoption/implementation is still ongoing for icobrain ct.
  • One Reddit user reported that their insurance did not cover the icobrain scan, costing an additional $75.
  • Some institutions may have site licenses that do not cover scans performed elsewhere, limiting its use with external imaging data.
  • The results of icobrain mr cross and icobrain mr long, two distinct image processing pipelines for MRI, cannot be compared with each other.
  • Limited independent reviews from healthcare IT, tech reviewers, G2, and Capterra were found.
  • One Reddit user did not find the icobrain scan to provide meaningful data, though this was an isolated comment.

Based on reviews from: icometrix.com, Moberg Analytics, YouTube, accessdata.fda.gov, X-ray Interpreter, Health AI Register, Elion, Reddit, RAYUS Radiology

Last updated: 2026-07-18

Ratings & Reviews

Rate icobrain-ctp

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

FDA
Icobrain-ctp Receives FDA Clearance
icobrain ctp, an image processing software package from Icometrix NV, received FDA clearance on February 28, 2020. It is designed for trained professionals to analyze CT perfusion scans of the brain, providing analysis and communication capabilities for dynamic imaging datasets.
2020-02
Journal of Clinical Medicine (via PMC)
Artificial Intelligence and Machine Learning in the Diagnosis and Management of Stroke: A Narrative Review of United States Food and Drug Administration-Approved Technologies
Published in May 2023, this review highlights icobrain CTP as an FDA-approved AI/ML-enabled technology for stroke diagnosis. It notes that icobrain CTP uses a Convolutional Neural Network (CNN) to estimate penumbra volumes and cerebral blood flow, showing strong correlations with expert radiologist assessments.
2023-05
British Journal of Radiology
Artificial intelligence in neuroradiology: a review of Food and Drug Administration-regulated algorithms
This article, published in May 2026, lists icobrain-CTP by Icometrix NV as an FDA-cleared medical image processing and analysis system (MIMPS) for processing perfusion data from CT scans, with its clearance date noted as February 28, 2020.
2026-05
NIHR Journals Library
Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis
A March 2024 report details icobrain CTP as part of the icobrain CT neuroimaging platform, a CE marked class 1 medical device. It provides a quantitative assessment of brain perfusion from CT scans with contrast, analyzing blood flow to identify potentially salvageable tissues in ischemic stroke.
2024-03
HLTH (Healthcare IT News)
AI-enabled MRI analysis receives US reimbursement code
An article from July 2023 mentions that icometrix secured $18M in funding in 2019 to expand its brain software and received FDA clearance for its icobrain-ctp offering in February 2020.
2023-07
Incepto Medical
icobrain cva CE - Incepto medical
Updated in June 2025, this page states that icobrain cva is a report generated by icobrain ctp, which is a CE marked, Class IIa medical device regulated by the EU MDR. It provides quantitative assessment of tissue perfusion and reports on core and perfusion lesion volumes.
2025-06
NICE
The diagnostic tests | Artificial intelligence (AI) software to help clinical decision making in stroke | CLONE OF DG57 - NICE
This NICE document from September 2023 describes icobrain ct, which includes the AI-derived algorithm icobrain ctp, for analyzing CT perfusion brain scans to identify potentially salvageable brain tissue in ischemic stroke. The annual cost for icobrain ct ranges from approximately u00a320,000 to u00a345,000.
2023-09
PMC (via Spandidos Publications)
Computational healthcare: Present and future perspectives (Review)
This review, accepted in July 2021, lists icobrain-ctp by Icometrix NV as a diagnostic tool in neuroradiology, cleared in 2020.
2021-12

Videos

Product demos, reviews, and walkthroughs for icobrain-ctp.

Loading videos...

View all on YouTube

Frequently Asked Questions

icobrain-ctp is an FDA-cleared and CE-marked AI-powered image processing software designed for computed tomography perfusion (CTP) scans of the brain. It provides automated analysis and quantification of parameters related to tissue flow and blood volume, aiding physicians in diagnosing and monitoring acute neurological conditions like stroke and traumatic brain injury by offering objective, quantitative data.
icobrain-ctp is FDA-cleared and CE-marked, indicating it meets regulatory standards for medical devices. Icometrix, the developer, is also ISO and HIPAA compliant, addressing data security and privacy concerns.
While CPT-III codes (0865T and 0866T) are active for icobrain's quantitative brain MRI analysis, providing a pathway for reimbursement, specific codes for icobrain-ctp were not explicitly found in the search results. However, a recent proposed Medicare ruling suggests potential challenges for coverage of AI-based brain MRI technologies due to concerns about clinical utility and data diversity.
Limitations of CTP in general, which may apply to icobrain-ctp, include a lack of standardization in acquisition protocols, susceptibility to motion artifacts, and potential for under- or overestimation of infarct core or penumbra volumes. Additionally, CTP primarily reflects perfusion status and does not directly indicate irreversible tissue damage as definitively as MRI-DWI.
icobrain-ctp is one of several AI-derived software solutions for stroke analysis, with alternatives including products from Aidoc, MaxQ AI (Accipio), Nanox.AI (Neuro Solution), Cercare Medical (Cercare Perfusion), and RapidAI (Ischemaview). While AI aims to improve consistency and speed over traditional visual interpretation, the effectiveness of different software and thresholds in CTP analysis is an ongoing area of study.
While specific pricing for icobrain-ctp was not detailed, icometrix's related products often follow a subscription-based model, with costs potentially tied to the number of analyses performed. The impact on hospital budgets would depend on the volume of use and the extent of reimbursement, which is currently a developing area for AI in neuroimaging.

Related Tools

Nelli (Version 7.11)
Neuro Event Labs Oy
Neurology AI
Nelli is an AI-driven video and audio monitoring system designed to identify and prioritize the review of seizure events with positive motor components, primarily for epilepsy diagnostics and monitoring.
Rapid Enterprise Platform
RapidAI
Cardiology AI
RapidAI's Enterprise Platform offers FDA-cleared, deep clinical AI solutions that connect imaging to clinical action across the health system, integrating with EHRs and PACS for enhanced decision-making and workflow efficiency.
Neuropacs Parkinsonian Syndromes
Neuropacs
Clinical Decision Support & Reference
Neuropacs™ is an FDA-cleared AI-based software that analyzes patient-specific diffusion MRI data to help radiologists and neurologists differentiate Parkinson's disease from atypical parkinsonian syndromes like multiple system atrophy Parkinsonian variant (MSAp) and progressive supranuclear palsy (PSP).
StateViewer
Mayo Clinic
Clinical Decision Support & Reference
Mayo Clinic's StateViewer is an AI platform under research that analyzes PET scans to identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, aiding in early and precise diagnosis. It has shown to improve diagnostic accuracy and speed of interpretation for clinicians.
NaoTrac
Brain Navi Biotechnology
Neurology AI
NaoTrac is an autonomous neurosurgical navigation robot with AI and machine vision, designed to improve accuracy, streamline procedures, and assist in surgical pathway planning with 3D vision.
GIA® by Scienza Health
Scienza Health
Clinical Decision Support & Reference
GIA® by Scienza Health is a multimodal AI screening platform that combines speech biomarkers with computer vision data to screen for cognitive, neurological, and behavioral conditions like Parkinson's disease and cognitive decline.

See all Neurology AI tools →

More from icometrix NV

Icobrain
Icometrix NV
Neurology AI
Icobrain is an AI-powered software by Icometrix NV that analyzes brain MRI and CT scans to provide quantitative insights for neurological conditions such as multiple sclerosis, dementia, Alzheimer's, stroke, epilepsy, and traumatic brain injury. It is FDA-cleared and CE-marked, assisting clinicians in diagnosis, monitoring, and treatment assessment.
icobrain aria
icometrix NV
Neurology AI
icobrain aria is an AI-powered software by icometrix for automated detection, measurement, and severity assessment of Amyloid-Related Imaging Abnormalities (ARIA) on brain MRI scans, crucial for monitoring Alzheimer's patients on amyloid-targeting therapies.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.